📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Sodium valproate, a potential repurposed treatment for the neurodegeneration in Wolfram syndrome (TREATWOLFRAM): trial protocol for a pivotal multicentre, randomised double-blind controlled trial. (2025)

First Author: Dias RP

Attributed to: Development of a novel repurposed drug treatment for the neurodegeneration and diabetes in Wolfram syndrome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2024-091495

PubMed Identifier: 40010822

Publication URI: http://europepmc.org/abstract/MED/40010822

Type: Journal Article/Review

Volume: 15

Parent Publication: BMJ open

Issue: 2

ISSN: 2044-6055